Effectiveness of Varicella Zoster Immune Globulin Administration within 96 Hours versus more than 96 Hours after Exposure to the Varicella-Zoster Virus |
Kim, Sun-Ja
(Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Byung-Kee (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Yang-Hyun (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Soo-Jin (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, et al. PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child 2011;96:841-5. DOI |
2 | Weinstock DM, Boeckh M, Boulad F, Eagan JA, Fraser VJ, Henderson DK, et al. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues. Infect Control Hosp Epidemiol 2004;25:603-8. DOI |
3 | Salzman MB, Garcia C. Postexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J 1998;17:256-7. DOI |
4 | Brunell PA, Ross A, Miller LH, Kuo B. Prevention of varicella by zoster immune globulin. N Engl J Med 1969;280:1191-4. DOI |
5 | Brunell PA, Gershon AA, Hughes WT, Riley HD, Jr., Smith J. Prevention of varicella in high risk children: a collaborative study. Pediatrics 1972;50:718-22. |
6 | Zaia JA, Levin MJ, Preblud SR, Leszczynski J, Wright GG, Ellis RJ, et al. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis 1983;147:737-43. DOI |
7 | A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 2006;55:209-10. |
8 | FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella. MMWR Morb Mortal Wkly Rep 2012;61:212. |
9 | Enders G, Bolley I, Miller E, Cradock-Watson J, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. The Lancet 1994;343:1548-51. DOI |
10 | Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-5. |
11 | Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: Seventy-seven cases. Pediatrics 1975;56:388-97. |
12 | Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis 2008;197 Suppl 2:S200-6. DOI |
13 | Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-40. |
14 | Orenstein WA, Heymann DL, Ellis RJ, Rosenberg RL, Nakano J, Halsey NA, et al. Prophylaxis of varicella in high-risk children: dose-response effect of zoster immune globulin. J Pediatr 1981;98:368-73. DOI |
15 | Updated recommendations for use of VariZIG--United States, 2013. MMWR Morb Mortal Wkly Rep 2013;62:574-6. |
16 | Winsnes R. Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients. Acta Paediatr Scand 1978;67:77-82. |
17 | Evans EB, Pollock TM, Cradock-Watson JE, Ridehalgh MK. Human anti-chickenpox immunoglobulin in the prevention of chickenpox. Lancet 1980;1:354-6. |
18 | Enders G ME. Varicella-zoster virus: virology and clinical management. In: Varicella and herpes zoster in pregnancy and the newborn. Cambridge, UK: Cambridge University Press, 2000. |
19 | Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red book 2012:p92, p774-81. |
20 | Koren G, Money D, Boucher M, Aoki F, Petric M, Innocencion G, et al. Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women. J Clin Pharmacol 2002;42:267-74. DOI |
21 | Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 2007;92:1062-6. DOI |
22 | Balfour HH, Jr. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med 1988;85:68-73. DOI |
23 | Swingler G. Chickenpox. Clin Evid 2003:755-62. |
24 | Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45:1-36. |
25 | Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361-81. |
26 | Roderick M, Finn A, Ramanan AV. Chickenpox in the immunocompromised child. Arch Dis Child 2012;97:587-9. DOI |
27 | Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987;80:465-72. |
28 | Brandt L, Broadbent V. A survey of recommendations given to patients going home after bone marrow transplant. Arch Dis Child 1994;71:529-31. DOI |
29 | Weinstock DM, Boeckh M, Sepkowitz KA. Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2006;12:1096-7. DOI |